Skip to content
  1. Home/
  2. Latest news/
  3. Innovation/
  4. 4 ways Johnson & Johnson has helped cultivate future STEM leaders
A photo of people working with drones

4 ways Johnson & Johnson has helped cultivate future STEM leaders

In 2018, an estimated 20% of all U.S. jobs will require a high level of knowledge in science, technology, engineering or math—commonly referred to as STEM fields.

You’ve probably heard a lot about these hot careers in the news as of late, but helping to prep and nurture the STEM movers and shakers of tomorrow certainly isn’t a new concept for Johnson & Johnson.

Over the past 25 years, the company has created several programs specifically designed to help everyone from grade schoolers to women succeed in future STEM careers.

Initiatives like the new WiSTEM2D Scholars Program, which starts taking applications September 1.

The program—which is open to nontenured assistant female professors or the global equivalent at tenure-granting accredited academic universities, institutions or design schools—will fund one woman per area of STEM2D concentration: science, technology, engineering, math, manufacturing and design.

The six award winners will receive $150,000 in funding over three years, as well as support from Johnson & Johnson mentors and other industry leaders.

Learn more about how Johnson & Johnson hopes to ignite future STEM2D breakthroughs through this program and others in this infographic.


4 Ways Johnson & Johnson Has Helped Cultivate Future STEM Leaders

Wanted: The women leaders of tomorrow

Learn how Johnson & Johnson is igniting the power of women to inspire the next generation of healthcare movers and shakers.

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.